BCPS Exam Questions with
Correct Answers
____ is the most appropriate answer because there are no drug-drug interactions or
contraindications / cautions in HIV - ANSWER - Bictegravir
n patients with persistent neutropenic fever despite anti-pseudomonal coverage,
what should be considered? - ANSWER - empiric antifungal therapy should be
considered after 4 - 10 days
electrocautery - ANSWER - Which of the following therapies is most likely to result in
a resolution rate which approaches 100% in patients w/ external anogenital warts.?
preferred therapy for CMV retinitis? - ANSWER - Ganciclovir intravitreal injections
plus valganciclovir oral
bacterial vaginosis recommended treatment - ANSWER - clindamycin or
metronidazole
(i.e. Clindamycin 300 mg orally twice daily for 7 days)
recommended treatment regimen for pelvic inflammatory disease - ANSWER -
Ceftriaxone 250 mg intramuscularly x 1 dose plus doxycycline 100 mg orally twice
daily for 14 days
vulvovaginal candidiasis teeatment - ANSWER - Clindamycin cream 2%, 5 g
intravaginally at bedtime for 7 days
MedWatch - ANSWER - preferred route for healthcare professionals and patients to
report suspected adverse events to the FDA
FDA Form 3500A - ANSWER - mechanism for reporting suspected adverse events,
but is reserved for use by user-facilities, importers, distributors, and manufacturers
, -reporting errors related to vaccines - ANSWER - ISMP VERP and VAERS
viral rhinosinusitis sx duration - ANSWER - -peak at 3 days and may persist longer
than 14 days but usually decreases in severity by 10 days
BRAF Mutation - ANSWER - BRAF mutation confers resistance to EGFR inhibitors;
Anti-EGFR therapies should be avoided in KRAS WT and BRAF mutant mCRC unless
given in combination with BRAF inhibitor
Palbociclib - ANSWER - -FDA approval for male breast cancer in combination with an
aromatase inhibitor or fulvestrant for men with hormone receptor-positive (HR+),
human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic
breast cancer
Atezolizumab combined with nab-paclitaxel - ANSWER - -in breast CA is based on
the PD-L1 expression on tumor-infiltrating immune cells
-watchful waiting is recommended to avoid overuse of antibiotics as episodes are
often self-limited
Malignant external otitis treatment - ANSWER - - predominantly caused by
Pseudomonas aeruginosa
-antipseudomonal antimicrobials are considered the mainstay of therapy.
Fidaxomicin - ANSWER - -associated with decreased recurrence of Clostridioides
difficile likely owing to its narrow spectrum and minimal effect on normal colonic
flora
duration of initial therapy for CDI? - ANSWER - 10 days with oral vancomycin or
fidaxomicin
Correct Answers
____ is the most appropriate answer because there are no drug-drug interactions or
contraindications / cautions in HIV - ANSWER - Bictegravir
n patients with persistent neutropenic fever despite anti-pseudomonal coverage,
what should be considered? - ANSWER - empiric antifungal therapy should be
considered after 4 - 10 days
electrocautery - ANSWER - Which of the following therapies is most likely to result in
a resolution rate which approaches 100% in patients w/ external anogenital warts.?
preferred therapy for CMV retinitis? - ANSWER - Ganciclovir intravitreal injections
plus valganciclovir oral
bacterial vaginosis recommended treatment - ANSWER - clindamycin or
metronidazole
(i.e. Clindamycin 300 mg orally twice daily for 7 days)
recommended treatment regimen for pelvic inflammatory disease - ANSWER -
Ceftriaxone 250 mg intramuscularly x 1 dose plus doxycycline 100 mg orally twice
daily for 14 days
vulvovaginal candidiasis teeatment - ANSWER - Clindamycin cream 2%, 5 g
intravaginally at bedtime for 7 days
MedWatch - ANSWER - preferred route for healthcare professionals and patients to
report suspected adverse events to the FDA
FDA Form 3500A - ANSWER - mechanism for reporting suspected adverse events,
but is reserved for use by user-facilities, importers, distributors, and manufacturers
, -reporting errors related to vaccines - ANSWER - ISMP VERP and VAERS
viral rhinosinusitis sx duration - ANSWER - -peak at 3 days and may persist longer
than 14 days but usually decreases in severity by 10 days
BRAF Mutation - ANSWER - BRAF mutation confers resistance to EGFR inhibitors;
Anti-EGFR therapies should be avoided in KRAS WT and BRAF mutant mCRC unless
given in combination with BRAF inhibitor
Palbociclib - ANSWER - -FDA approval for male breast cancer in combination with an
aromatase inhibitor or fulvestrant for men with hormone receptor-positive (HR+),
human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic
breast cancer
Atezolizumab combined with nab-paclitaxel - ANSWER - -in breast CA is based on
the PD-L1 expression on tumor-infiltrating immune cells
-watchful waiting is recommended to avoid overuse of antibiotics as episodes are
often self-limited
Malignant external otitis treatment - ANSWER - - predominantly caused by
Pseudomonas aeruginosa
-antipseudomonal antimicrobials are considered the mainstay of therapy.
Fidaxomicin - ANSWER - -associated with decreased recurrence of Clostridioides
difficile likely owing to its narrow spectrum and minimal effect on normal colonic
flora
duration of initial therapy for CDI? - ANSWER - 10 days with oral vancomycin or
fidaxomicin
